B.Riley on Viking Therapeutic (VKTX): 'we continue to see an attractive setup'

September 8, 2026 1:20 PM

B.Riley analyst Mayank Mamtani reiterated a Buy rating and $85.00 price target on Viking Therapeutic (NASDAQ: VKTX).The analyst comments "We ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found